Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.
If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...
Cognitive rehabilitation focuses on remediating the cognitive deficits of schizophrenia. A brief rationale and description of each approach and a summary of recent research are presented below.
2 天
Medpage Today on MSNAI Model Predicts Schizophrenia, Bipolar Progression Using EHR DataA machine learning model trained on electronic health record (EHR) data predicted progression to schizophrenia or bipolar ...
During acute episodes, patients may experience psychotic symptoms that impair their ability to control thoughts, emotions and ...
The effect of Caplyta was measured using a rating scale that evaluates how severe schizophrenia symptoms are. Higher scores mean more severe symptoms. Most people had severe symptoms of ...
A comprehensive analysis has identified novel enhancers associated with neuronal development and disease.
The following is a summary of “Management of Psychosis and Schizophrenia by Primary Care GPs: A Cross-Sectional Study in ...
and those with severe head injury. Medscape Medical News, June 18, 2024 Cat Scratch Fever Pathogen Linked to Schizophrenia Adults with psychosis were three times more likely to have evidence of ...
FDA convened a joint meeting of its Drug Safety and Risk Management Advisory Committee and the Psychopharmacologic Drugs ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果